| ★ | Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD | | 60 | Estados Unidos | |
| 14 | Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D | | 1.6K | Estados Unidos | 69 |
| 3 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 73 |
| 8 | Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss | | 250 | Estados Unidos | 70 |
| 20 | Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy | | 233 | Estados Unidos | 68 |
| 10 | Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation | | 217 | Estados Unidos | 69 |
| 18 | Cases from the Dyspnea Clinic | John J. Ryan, MD, MB, BCH, BAO | Minneapolis Heart Institute Foundation @mplsheartinstfound | 166 | Estados Unidos | 68 |
| 16 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 69 |
| 5 | Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk | | 120 | Estados Unidos | 73 |
| 7 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 71 |
| 12 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 69 |
| 19 | Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy | | 55 | Estados Unidos | 68 |
| 2 | Adam Friedman, MD, on CSU Treatment Updates | HCPLive | | 47 | Estados Unidos | 73 |
| 13 | Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment | | 46 | Estados Unidos | 69 |
| 4 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 73 |
| 6 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 72 |
| 11 | When IBD Symptoms Don't Match Inflammation, With Jordan Axelrad, MD, MPH | | 25 | Estados Unidos | 69 |
| 9 | Predicting Post-BLVR Pneumothorax With Quantitative CT | ATS 2026 | | 23 | Estados Unidos | 70 |
| 1 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 74 |
| 17 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 69 |
| 15 | How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD | | 13 | Estados Unidos | 69 |